American Society of Clinical Oncology

SHERPA: White

People

  1. Bajorin
    Bajorin
  2. Bosl
    Bosl
  3. Motzer
    Motzer
  4. Sheinfeld
    Sheinfeld
  5. Pfister
    Pfister
  6. Shaha
    Shaha
  7. Shah
    Shah
  8. Vickers
    Vickers

Groups

  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Surgery (4)
  4. Survivorship Research (4)
  5. Genitourinary Oncology Service (3)
  6. Urology (3)
  7. Epidemiology and Biostatistics (1)
  8. Head and Neck Service (1)
  9. Health Outcomes Research Group (1)
  10. Population Sciences Research Program (1)
Search Within
  1. "2004"
  2. "George Bosl"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Surgery (4)
  4. Survivorship Research (4)
  5. Genitourinary Oncology Service (3)
  6. Urology (3)

More Groups

People
  1. George Bosl (4)
  2. Dean Bajorin (3)
  3. Joel Sheinfeld (3)
  4. Robert Motzer (3)
  5. Gnanamba Kondagunta (2)
  6. Jennifer Bacik (2)

More People

Years
  1. 2004 (4)
Publications
  1. Journal of Clinical Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): Impact on mucositis
    Meeting Abstract

    Su, Y. B.; Vickers, A.; Zelefsky, M. J.; Kraus, D. H.; Shaha, A. R.; Shah, J. P.; Lake, S.; Harrison, L. B.; Bosl, G. J.; Pfister, D. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Primary retroperitoneal lymph node dissection (RPLND) for non-seminomatous germ-cell tumor (NSGCT): Impact of trends in patient selection on retroperitoneal pathology and outcome
    Meeting Abstract

    Stephenson, A. J.; Bosl, G. J.; Motzer, R. J.; Bajorin, D. F.; Stasi, J. P.; Sheinfeld, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) chemotherapy for good risk germ cell tumors (GCT): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Kondagunta, G. V.; Bacik, J.; Bajorin, D.; Mazumdar, M.; Dobrzynski, D.; Sheinfeld, J.; Motzer, R. J.; Bosl, G. J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy
    Journal Article

    Kondagunta, G. V.; Sheinfeld, J.; Mazumdar, M.; Mariani, T. V.; Bajorin, D.; Bacik, J.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save